✦ LIBER ✦

Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer

✍ Scribed by Kimberly A Moore; Carlos M Mery; Michael T Jaklitsch; Anastasia P. Estocin; Raphael Bueno; Scott J Swanson; David J Sugarbaker; Jeanne M Lukanich

Book ID: 117036304
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 116 KB
Volume: 76
Category: Article
ISSN: 0003-4975
DOI: 10.1016/s0003-4975(03)01024-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Present and future treatment of advanced

Present and future treatment of advanced non–small cell lung cancer

✍ Lucio Crinò; Federico Cappuzzo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Pilot study of gefitinib and fulvestrant

Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer

✍ Traynor, Anne M.; Schiller, Joan H.; Stabile, Laura P.; Kolesar, Jill M.; Eickho 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Antiestrogen Use and Survival of Women w

Antiestrogen Use and Survival of Women with Non-small Cell Lung Cancer in Manitoba, Canada

✍ S. A. Lother, G. A. Harding, G. Musto, S. Navaratnam, M. W. Pitz 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 191 KB

Impact of Staging Endosonography On Trea

Impact of Staging Endosonography On Treatment and Survival in Patients with Non-Small Cell Lung Cancer

✍ Mohamad Eloubeidi; Renee Desmond; Shilpa Desai; Mohit Mehra; Ayesha Bryant; Robe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Present status and problems of surgical

Present status and problems of surgical treatment of non-small cell lung cancer

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Impact of staging transesophageal EUS on

Impact of staging transesophageal EUS on treatment and survival in patients with non-small-cell lung cancer

✍ Mohamad A. Eloubeidi; Renee Desmond; Shilpa Desai; Mohit Mehra; Ayesha Bryant; R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 315 KB

## Background: Transesophageal eus-guided fna (eus-fna) is safe, accurate, and cost effective in staging patients with non-small-cell lung cancer (nsclc). however, the impact of eus-fna on patient survival has not been demonstrated. ## Objective: To determine the impact of metastatic disease in m